Settlement without Signatures: Federal Circuit Orders that Parties Memorialize Oral Agreement
On July 24, 2014, the Federal Circuit ordered that Endo Pharmaceuticals Inc. and Mylan Pharmaceuticals Inc. were required to continue their attempts to memorialize a previously-agreed-to settlement in a patent-litigation suit relating to Endo’s Frova tablets, a frovatriptan succinate EQ medication that treats migraine headaches. Specifically, the Federal Circuit denied Endo’s bid for an emergency…